GHCM
ABMD

Glen Harbor Capital Management’s Abiomed Inc ABMD Stock Holding History

Glen Harbor Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$835K Buy
4,692
+952
+25% +$206K 0.02% 520
2019
Q2 		$974K Buy
3,740
+204
+6% +$54.1K 0.02% 486
2019
Q1 		$1.01M Buy
3,536
+408
+13% +$136K 0.02% 468
2018
Q4 		$1.02M Sell
3,128
-272
-8% -$94.5K 0.02% 436
2018
Q3 		$1.53M Sell
3,400
-8,296
-71% -$3.27M 0.03% 384
2018
Q2 		$4.78M Buy
11,696
+1,462
+14% +$530K 0.1% 194
2018
Q1 		$2.98M Buy
10,234
+476
+5% +$121K 0.07% 234
2017
Q4 		$1.83M Buy
9,758
+3,298
+51% +$616K 0.04% 314
2017
Q3 		$1.09M Buy
6,460
+680
+12% +$103K 0.03% 391
2017
Q2 		$828K Buy
5,780
+2,380
+70% +$320K 0.02% 465
2017
Q1 		$426K Sell
3,400
-748
-18% -$86.7K 0.01% 596
2016
Q4 		$468K Buy
+4,148
New +$481K 0.01% 521

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Glen Harbor Capital Management's ABMD Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Abiomed Inc (ABMD) stake by 25% in Q3 2019, buying an estimated $206K and bringing the position to 4,692 shares worth $835K. The position accounts for 0.02% of the portfolio, ranked #520.

Glen Harbor Capital Management first reported a position in ABMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $4.78M in Q2 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Glen Harbor Capital Management held 4,692 shares of Abiomed Inc worth $835K as of Q3 2019.
  • Glen Harbor Capital Management bought 952 Abiomed Inc shares in Q3 2019, an estimated $206K.
  • Abiomed Inc made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #520 holding.
  • Glen Harbor Capital Management first reported a position in Abiomed Inc in Q4 2016 and has held it in 12 quarters since.
  • Glen Harbor Capital Management's Abiomed Inc position peaked at $4.78M in Q2 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.